| Effect of gamma 2-melanocyte-stimulating hormone on cerebral blood flow in rats. | |
| | |
MedLine Citation:
|
PMID: 7564334 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effects of the proopiomelanocortin-(POMC)-derived peptide gamma 2-melanocyte-stimulating hormone (gamma 2-MSH) on mean arterial blood pressure (BP: MAP), heart rate (HR), internal and total carotid blood flow (BF) (CFint and CFtot, respectively), and regional cerebrocortical blood flow (CBF) were measured in urethane-anesthetized rats after intravenous (i.v.) and intracarotid (i.car.) administration of the peptide. gamma 2-MSH (1.5-100 nmol/kg) administered i.v. and i.car. caused a dose-dependent increase in MAP and HR. Injection of the peptide i.car. in the middose range resulted in a more pronounced pressor effect. Furthermore, the earlier onset of the hemodynamic effects after i.car. injection suggests that forebrain structures play a role in these effects. In addition to the pressor response, gamma 2-MSH produced a strong increase in CFint, CFtot, and CBF after both routes of administration, suggesting an increased intracerebral BF. Whereas the effects of the higher doses of gamma 2-MSH on MAP and CFtot were quantitatively comparable after either the intravenous or intracarotid administration, the effect on regional CBF and CFint was about twice as high after i.car. infusion, indicating a centrally mediated phenomenon underlying this effect on CBF. The increase in CFint cannot in itself be ascribed to a gamma 2-MSH-mediated higher perfusion pressure (i.e., BP), since an equipressor dose of norepinephrine (NE) caused a significant decrease in CFint. The significant and more than twofold higher increase in CBF after intracarotid administration of gamma 2-MSH in comparison with administration of NE by the same route also suggests a central origin for the enhancement of microcirculatory flow due to the peptide. |
| | |
Authors:
|
D J de Wildt; C M Kasbergen; D H Versteeg |
Related Documents
:
|
11165354 - Cardiovascular reactions induced by unpredictable, predictable, and controllable painfu... 10090294 - Circadian variation in blood pressure: implications for the elderly patient. 1464894 - Usefulness of self-measured blood pressure when diagnosing mild hypertension. 2764134 - A dynamic analysis of cardiovascular regulation using sinusoidal acceleration in dogs. 10386254 - Pulmonary complications of mechanical ventilation. 11165354 - Cardiovascular reactions induced by unpredictable, predictable, and controllable painfu... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 25 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 1995 Jun |
Date Detail:
|
Created Date: 1995-11-07 Completed Date: 1995-11-07 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 898-905 Citation Subset: IM |
Affiliation:
|
Department of Medical Pharmacology, Rudolf Magnus Institute for Neurosciences, Medical Faculty, Utrecht University, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Gas Analysis Blood Pressure / drug effects* Carotid Arteries / drug effects, physiology Cerebrovascular Circulation / drug effects* Dose-Response Relationship, Drug Heart Rate / drug effects* Injections, Intra-Arterial Injections, Intravenous Laser-Doppler Flowmetry Male Melanocyte-Stimulating Hormones / administration & dosage, pharmacology* Norepinephrine / pharmacology Rats Rats, Wistar Regional Blood Flow / drug effects Vasoconstrictor Agents / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Vasoconstrictor Agents; 51-41-2/Norepinephrine; 9002-79-3/Melanocyte-Stimulating Hormones |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics and pharmacodynamics of TP-9201, a GPIIbIIIa antagonist, in rats and dogs.
Next Document: Differences in onset of impaired endothelial responses and in effects of vitamin E in the hyperchole...